Cancer

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

New generation of SOPHiA DDMTM integrates latest advancements in data processing and technology to deliver elevated experience and capabilities to customers BOSTON…

1 year ago

Cairn Surgical Completes Enrollment in European Study of Novel Breast Cancer Locator System

LEBANON, N.H.--(BUSINESS WIRE)--#BCSM--Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today…

1 year ago

Compassion Center Urges DEA to Reschedule Cannabis to Schedule III During December 2, 2024, Hearing

Compassion Center urges the DEA to reschedule cannabis to Schedule III of the Controlled Substances Act during the December 2,…

1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),…

1 year ago

Space-Based Experiments to Advance Early Cancer Detection Through Blood Tests

University of Notre Dame researchers are leveraging the International Space Station National Laboratory to enhance biosensing technology for earlier cancer…

1 year ago

EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations

Support from the Brain Tumor Investment Fund, a subsidiary of the National Brain Tumor Society, and Sontag Innovation Fund Strengthens…

1 year ago

Health Union Launches First-of-Its-Kind People-based Data Engine

ILLUMINÉ™ Harnesses the Power of Community to Build Privacy-first, Persona-Based Media Solutions PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Health Union,…

1 year ago

Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate Health

The investment is a pivotal milestone allowing Segmed to further expand its medical imaging solutions for artificial intelligence development and…

1 year ago

PhaseV to Present at Upcoming Healthcare, Pharma and Technology Events

New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept.…

1 year ago

Cortechs.ai Receives FDA 510(k) Clearance for Groundbreaking NeuroQuant 5.0 Software, Expanding Support for Quantification of ARIA-E and ARIA-H

SAN DIEGO, Sept. 3, 2024 /PRNewswire/ -- Cortechs.ai, the leader in volumetric neuroimaging analysis, announces FDA 510(k) clearance for its NeuroQuant®…

1 year ago